Analysis of local aggressiveness and malignancy transformation potential of ameloblastoma through osteopontin and CD10 expression (Immunohistochemical research)
Authors:
Open Access
- 1 July 2025
- journal article
- Published by Wolters Kluwer Health in Journal of Oral and Maxillofacial Pathology
- Vol. 29 (3) , 382-388
Abstract
Background: Ameloblastoma is a benign, slow-growing odontogenic neoplasia that can infiltrate soft tissue and penetrate bone. Molecular markers like IHC staining with Osteopontin and CD10 antibodies can help understand the abnormalities and predict malignant transformation. This study aims to improve diagnosis and treatment by tracking these indicators alongside other clinicopathological aspects. Material and Methods: The study analyzed the correlation between OPN and CD10 expression and ameloblastoma aggressiveness and malignant transformation using 35 paraffin blocks. IHC staining was performed using OPN and CD10 markers, and cell counts and staining intensities were calculated using the IRS method. The IRS score was correlated with clinicopathological parameters using statistical tests (P < 0.05). Results: The results of the OPN expression examination are strong (37.2%), moderate (37.2%), weak (17.1%), and negative (8.5%) Meanwhile, the results of the CD10 expression examination are moderate (28.6%), weak (54.2%), and negative (17.2%). Correlation test for OPN and CD10 expression is P = 0.940. Correlation test for OPN expression and each clinicopathological feature is radiographic appearance P = 0.708, root resorption P = 0.063, tumour progression P = 0.640, tumour size P = 0.428, tumour duration P = 0.477, and regional lymph nodes enlargement P = 0.687. Correlation test for CD10 expression and each clinicopathological feature is radiographic appearance P = 0.342, tumour progression P = 0.623, root resorption P = 0.940, tumor size P = 0.003, tumor duration P = 0.138, and regional lymph nodes enlargement P = 0.858. Conclusions: Ameloblastoma aggressiveness is indicated by high OPN and CD10 expression, while malignancy transformation potential is indicated by high OPN and low CD10 expression, with CD10 expression correlated with tumor size.Keywords
This publication has 29 references indexed in Scilit:
- High level of CD10 expression is associated with poor overall survival in patients with head and neck cancerInternational Journal of Oral and Maxillofacial Surgery, 2021
- Tumour suppression through modulation of neprilysin signaling: A comprehensive reviewEuropean Journal of Pharmacology, 2021
- The tumor microenvironmentCurrent Biology, 2020
- Odontogenic keratocyst and ameloblastoma: radiographic evaluationOral Radiology, 2020
- Study of Ki67 and CD10 expression as predictive factors of recurrence of ameloblastomaEuropean Annals of Otorhinolaryngology, Head and Neck Diseases, 2015
- Concise Review: Neutral Endopeptidase (CD10): A Multifaceted Environment Actor in Stem Cells, Physiological Mechanisms, and CancerStem Cells, 2011
- Clinicopathological study and treatment outcomes of 121 cases of ameloblastomasInternational Journal of Oral and Maxillofacial Surgery, 2010
- Growth characteristics of large mandibular ameloblastomas: report of 5 cases with implications for the approach to surgeryInternational Journal of Oral and Maxillofacial Surgery, 2006
- CD10 expression in pancreatic endocrine tumors: correlation with prognostic factors and survivalHuman Pathology, 2006
- Loss of CD10 (neutral endopeptidase) is a frequent and early event in human prostate cancerThe Prostate, 2003